Dr. Jonathon Javitt, Founder, Director & Chief Scientific Officer of NRX Pharmaceuticals, discusses the company’s work addressing akathisia and suicidal depression, along with new developments surrounding ketamine, PTSD and its collaboration with Columbia University.
February 7, 2023
